Brief: Sino Biopharmaceutical Posts Qtrly Profit Attributable Of RMB1.15 Bln
30/10/2024 15:23
Oct 30 (Reuters) - Sino Biopharmaceutical Ltd 1177.HK :
* QTRLY PROFIT ATTRIBUTABLE RMB1.15 BILLION
* QTRLY REVENUE RMB5.47 BILLION, UP 14.3%
Further company coverage: 1177.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sino Biopharmaceutical
See all newsHong Kong stocks end higher on pharma, tech gains
Hong Kong stocks climb, led by pharmaceutical, tech stocks
Brief: Sino Biopharmaceutical Says China's CDE Accepts NDA For TQH2722 Injection
Brief: Sino Biopharmaceutical China CDE Accepts New Drug Application For TQB2102 Injection
Sino Biopharmaceutical climbs on plan to raise stake in core unit